Publications by authors named "Ryuta Asada"

Claim this Profile
E
Efficacy and Safety of 48-Week Low-Dose Dienogest Treatment in Patients with Endometriosis-Associated Dysmenorrhea: A Randomized, Open-Label, Parallel-Group Trial.
Kyoko Kikuno, Ryuta Asada, Takuma Ishihara, Ken-Ichirou Morishige, Kenro Chikazawa

Adv Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Efficacy and Safety of 48-Week Low-Dose Dienogest Treatment in Patients with Endometriosis-Associated Dysmenorrhea: A Randomized, Open-Label, Parallel-Group Trial.
Kyoko Kikuno, Ryuta Asada, Takuma Ishihara, Ken-Ichirou Morishige, Kenro Chikazawa

Adv Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 Study of Crizotinib in Children With Relapsed/Refractory ALK-Positive Anaplastic Large Cell Lymphoma or Neuroblastoma in Japan.
Tetsuya Mori, Akiko Kada, Tomoo Osumi, Daisuke Tomizawa, Yuhki Koga, Ryuta Asada

Cancer Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed Messages: Dynamic and Compositional Heterogeneity of Nuclear Messenger Ribonucleoprotein (mRNP) Complexes.
Theresa Wechsler, Ryuta Asada, Ben Montpetit

Wiley Interdiscip Rev RNA· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A time-resolved framework for the recruitment of mRNP processing and assembly factors to a site of transcription.
Theresa Wechsler, Ryuta Asada, Andrew N M Dominguez, Rachel Montpetit, Julia K McCormick

Nucleic Acids Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of cardiac rehabilitation exercise management on improving exercise tolerance among patients with chronic heart disease using a telemetry-based biosignal measurement device: protocol for a multicentre randomised controlled trial in Japan (iCARE-MATE study).
Junya Yamagishi, Takatomo Watanabe, Jun Matsumoto-Miyazaki, Yuki Sahashi, Daichi Watanabe, Ryuta Asada

BMJ Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Efficacy and Safety of 48-Week Low-Dose Dienogest Administration in Patients With Dysmenorrhea Caused by Endometriosis: Protocol for a Randomized, Open-Label, Parallel-Group Trial.
Kyoko Kikuno, Ryuta Asada, Takuma Ishihara, Yoshimasa Bomoto, Saki Murase

JMIR Res Protoc· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sirolimus treatment for intractable vascular anomalies (SIVA): An open-label, single-arm, multicenter, prospective trial.
Michio Ozeki, Saori Endo, Shiho Yasue, Ryuta Asada, Akiko M Saito

Pediatr Int· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic analysis of sirolimus in Japanese pediatric and adult subjects receiving tablet or granule formulations.
Taichi Miyazaki, Daichi Hayashi, Akifumi Nozawa, Shiho Yasue, Saori Endo, Ryuta Asada

Drug Metab Pharmacokinet· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of aceneuramic acid in GNE myopathy: open-label extension study.
Naoki Suzuki, Madoka Mori-Yoshimura, Masahisa Katsuno, Masanori P Takahashi, Satoshi Yamashita, Ryuta Asada

J Neurol Neurosurg Psychiatry· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sirolimus treatment for intractable lymphatic anomalies: an open-label, single-arm, multicenter, prospective trial.
Michio Ozeki, Saori Endo, Shiho Yasue, Akifumi Nozawa, Ryuta Asada

Front Med (Lausanne)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gle1 is required for tRNA to stimulate Dbp5 ATPase activity in vitro and promote Dbp5-mediated tRNA export in vivo in .
Arvind Arul Nambi Rajan, Ryuta Asada, Ben Montpetit

Elife· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gle1 is required for tRNA to stimulate Dbp5 ATPase activity and to promote Dbp5 mediated tRNA export .
Arvind Arul Nambi Rajan, Ryuta Asada, Ben Montpetit

bioRxiv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-molecule quantitation of RNA-binding protein occupancy and stoichiometry defines a role for Yra1 (Aly/REF) in nuclear mRNP organization.
Ryuta Asada, Andrew Dominguez, Ben Montpetit

Cell Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlling nutritional status score during hospitalization as a predictor of clinical outcome in patients with aneurysmal subarachnoid hemorrhage.
Shinya Shimizu, Tatsunori Hanai, Yusuke Egashira, Yukina Sato, Kumiko Sekiya, Ryuta Asada

Sci Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy confirmation study of aceneuramic acid administration for GNE myopathy in Japan.
Madoka Mori-Yoshimura, Naoki Suzuki, Masahisa Katsuno, Masanori P Takahashi, Satoshi Yamashita, Ryuta Asada

Orphanet J Rare Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II/III Study of Aceneuramic Acid Administration for GNE Myopathy in Japan.
Naoki Suzuki, Madoka Mori-Yoshimura, Masahisa Katsuno, Masanori P Takahashi, Satoshi Yamashita, Ryuta Asada

J Neuromuscul Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Layered Regulations on the Chromatin Architectures: Establishing the Tight and Specific Responses of Fission Yeast Gene Transcription.
Ryuta Asada, Kouji Hirota

Biomolecules· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human FGF-2 for the treatment of early-stage osteonecrosis of the femoral head: TRION, a single-arm, multicenter, Phase II trial.
Yutaka Kuroda, Takeyuki Tanaka, Takaki Miyagawa, Hidetoshi Hamada, Hiroyasu Abe, Ryuta Asada

Regen Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Femoral head collapse rate among Japanese patients with pre-collapse osteonecrosis of the femoral head.
Ryuta Asada, Hiroyasu Abe, Hidetoshi Hamada, Yusuke Fujimoto, Hyonmin Choe

J Int Med Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Successful and Unsuccessful Cases of New Drug Approvals Based on the International Council on Harmonization E5 Guidelines in Japan.
Ryuta Asada, Shinobu Shimizu, Harumasa Nakamura, Shunsuke Ono, Takuhiro Yamaguchi

Clin Pharmacol Drug Dev· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evaluation of the safety and efficacy of intravenously administered allogeneic multilineage-differentiating stress-enduring cells in a swine hepatectomy model.
Masahiro Iseki, Masamichi Mizuma, Shohei Wakao, Yoshihiro Kushida, Katsuyoshi Kudo, Ryuta Asada

Surg Today· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
lncRNA transcription induces meiotic recombination through chromatin remodelling in fission yeast.
Satoshi Senmatsu, Ryuta Asada, Arisa Oda, Charles S Hoffman, Kunihiro Ohta

Commun Biol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topoisomerase activity is linked to altered nucleosome positioning and transcriptional regulation in the fission yeast fbp1 gene.
Ryuta Asada, Satoshi Senmatsu, Ben Montpetit, Kouji Hirota

PLoS One· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alectinib for relapsed or refractory anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: An open-label phase II trial.
Reiji Fukano, Tetsuya Mori, Masahiro Sekimizu, Ilseung Choi, Akiko Kada, Ryuta Asada

Cancer Sci· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis